Hiroya Masaki

Independent Researcher

101

Publications

5,932

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

Eriko Tateishi-Yuyama, Hiroaki Matsubara, Toyoaki Murohara, Uichi Ikeda, Satoshi Shintani +8 more

The Lancet 2002

1,732

Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines

Hiroshi Kamihata, Hiroaki Matsubara, Takashi Nishiue, Soichiro Fujiyama, Yoshiaki Tsutsumi +10 more

Circulation 2001

968

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. OA

Hiroya Masaki, Tatsuya Kurihara, Akira Yamaki, Norio Inomata, Yoshihisa Nozawa +10 more

Journal of Clinical Investigation 1998

260

Angiotensin Type 2 Receptors Are Reexpressed by Cardiac Fibroblasts From Failing Myopathic Hamster Hearts and Inhibit Cell Growth and Fibrillar Collagen Metabolism

Naohiko Ohkubo, Hiroaki Matsubara, Yoshihisa Nozawa, Yasukiyo Mori, Satoshi Murasawa +7 more

Circulation 1997

247

Angiotensin II Type 2 Receptor Is Upregulated in Human Heart With Interstitial Fibrosis, and Cardiac Fibroblasts Are the Major Cell Type for Its Expression

Yoshiaki Tsutsumi, Hiroaki Matsubara, Naohiko Ohkubo, Yasukiyo Mori, Yoshihisa Nozawa +9 more

Circulation Research 1998

241

Publications

101 total

PP.13.27: COMPARE THE TWO THERAPEUTIC COMBINATIONS OF ARB WITH DIURETIC PAY ATTENTION THE LEVEL OF URIC ACID

T. Yokoi, J. Azuma, Y. Taniyama, H. Masaki, R. Morishita - Unknown Venue, 2015

Cited by 2 Semantic Scholar

PP.06.27: AN EXAMINATION ABOUT EVALUATION OF BLOOD PRESSURE AND PULSE WAVE VELOCITY IN HEALTHY YOUNG PEOPLE OA

T. Yokoi, J. Azuma, Y. Taniyama, H. Masaki, R. Morishita - Unknown Venue, 2015

Cited by 0 Semantic Scholar

A novel frameshift mutation in exon 4 causing a deficiency of high-molecular-weight kininogen in a patient with splenic infarction. OA

N. Fukushima, H. Itamura, H. Wada, M. Ikejiri, Y. Igarashi - Internal medicine, 2014

Cited by 8 Semantic Scholar

Comparison between Two Calcium Antagonists: Blood Pressure Reduction and Renal Effects in Hypertensive Patients with Type 2 Diabetes

T. Yokoi, J. Azuma, Yukiyoshi Nakade, Fumihiro Sanada, K. Iekushi - Unknown Venue, 2012

Cited by 2 Semantic Scholar

940 COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES-

T. Yokoi, J. Azuma, Yukiyoshi Nakade, Fumihiro Sanada, K. Iekushi - Unknown Venue, 2012

Cited by 1 Semantic Scholar

Corrigendum to “Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: Evidence from vascular-targeted transgenic mice of AT2 receptor” [Biochem. Biophys. Res. Commun. 282 (2001) 1085–1091] OA

H. Matsubara, Y. Shibasaki, M. Okigaki, Y. Mori, H. Masaki - Unknown Venue, 2012

Cited by 0 Semantic Scholar

COMBINED EFFECTS OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN II RECEPTOR ANTAGONIST IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: PP.11.295

T. Yokoi, S. Nakade, H. Masaki, Hakuo Takahashi - Unknown Venue, 2011

Cited by 0 Semantic Scholar

Immunological kidney diseases (WS-098) Chairpersons: Yasuhiko Tomino, Jan Novak OA

M. Masuda, S. Morimoto, H. Y. Shi, T. Morita, N. Nishimura - Unknown Venue, 2010

Cited by 0 Semantic Scholar

[Case of spuriously high level of squamous cell carcinoma antigen in patient without carcinoma--HPLC and ultrafiltration are useful to analyze the true value].

Y. Komiyama, A. Ikuta, T. Ozaki, M. Munakata, N. Nishimura - Rinsho byori. The Japanese journal of clinical pathology, 2010

Cited by 0 Semantic Scholar

Pitavastatin Further Decreases Serum High-Sensitive C-Reactive Protein Levels in Hypertensive Patients with Hypercholesterolemia Treated with Angiotensin II, Type-1 Receptor Antagonists

M. Yoshika, Y. Komiyama, M. Masuda, T. Yokoi, H. Masaki - Clinical and experimental hypertension, 2010

Cited by 5 Semantic Scholar

Research Topics

Renin-Angiotensin System Studies (17) Receptor Mechanisms and Signaling (17) Angiogenesis and VEGF in Cancer (14) Mesenchymal stem cell research (9) Ion channel regulation and function (8)

Frequent Co-Authors

Toshiji Iwasaka

14 joint publications

Hiroaki Matsubara

13 joint publications

Yasukiyo Mori

12 joint publications

Katsuya Maruyama

9 joint publications

Satoshi Murasawa

8 joint publications

Yoshihisa Nozawa

7 joint publications

Affiliations

Setsunan University

JP 2006 - 2006

Hiroshima University

JP 2001 - 2001

Tokyo Medical and Dental University

JP 2005 - 2005

Kansai Medical University

JP 2015 - 1990

Monash Medical Centre

AU 2010 - 2010

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Hiroya Masaki

Publication & Citation Trends

Most Cited Works

Publications

PP.13.27: COMPARE THE TWO THERAPEUTIC COMBINATIONS OF ARB WITH DIURETIC PAY ATTENTION THE LEVEL OF URIC ACID

PP.06.27: AN EXAMINATION ABOUT EVALUATION OF BLOOD PRESSURE AND PULSE WAVE VELOCITY IN HEALTHY YOUNG PEOPLE OA

A novel frameshift mutation in exon 4 causing a deficiency of high-molecular-weight kininogen in a patient with splenic infarction. OA

Comparison between Two Calcium Antagonists: Blood Pressure Reduction and Renal Effects in Hypertensive Patients with Type 2 Diabetes

940 COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES-

Corrigendum to “Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: Evidence from vascular-targeted transgenic mice of AT2 receptor” [Biochem. Biophys. Res. Commun. 282 (2001) 1085–1091] OA

COMBINED EFFECTS OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN II RECEPTOR ANTAGONIST IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: PP.11.295

Immunological kidney diseases (WS-098) Chairpersons: Yasuhiko Tomino, Jan Novak OA

[Case of spuriously high level of squamous cell carcinoma antigen in patient without carcinoma--HPLC and ultrafiltration are useful to analyze the true value].

Pitavastatin Further Decreases Serum High-Sensitive C-Reactive Protein Levels in Hypertensive Patients with Hypercholesterolemia Treated with Angiotensin II, Type-1 Receptor Antagonists

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back